Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group

Journal of Hepatology

Volumn 41, Issue 4, 2004, Pages 677-683

  Vergani, Diego ^a   Alvarez, Fernando ^b   Bianchi, Francesco B ^c   Cançado, Eduardo L R ^d   MacKay, Ian R ^e   Manns, Michael P ^f   Nishioka, Mikio ^g   Penner, Edward ^h  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MONTREAL   (Canada)

^c Policlin S Orsola U ^*  (Italy)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e MONASH UNIVERSITY   (Australia)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g N   (Japan)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE HEPATITIS; DILUTION; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROLOGY;

EID: 4644308514     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.08.002     Document Type: Review

References (60)

1. P.J. Johnson, and I.G. McFarlane Meeting report: International Autoimmune Hepatitis Group Hepatology 18 1993 998 1005
2. F. Alvarez, P.A. Berg, F.B. Bianchi, L. Bianchi, A.K. Burroughs, and E.L. Cancado International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938
3. G.V. Gregorio, B. Portmann, F. Reid, P.T. Donaldson, D.G. Doherty, and M. McCartney Autoimmune hepatitis in childhood: a 20-year experience Hepatology 25 1997 541 547
4. J.C. Homberg, N. Abuaf, O. Bernard, S. Islam, F. Alvarez, and S.H. Khalil Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of autoimmune hepatitis Hepatology 7 1987 1333 1339
5. S.L. Taylor, P.J. Dean, and C.A. Riely Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis Am J Surg Pathol 18 1994 91 99
6. G.V. Gregorio, B. Portmann, J. Karani, P. Harrison, P.T. Donaldson, and D. Vergani Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study Hepatology 33 2001 544 553
7. D.S. Pratt, and M.M. Kaplan Evaluation of abnormal liver-enzyme results in asymptomatic patients N Engl J Med 342 2000 1266 1271
8. E. Bonifacio, P.J. Bingley, M. Shattock, B.M. Dean, D. Dunger, and E.A. Gale Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes Lancet 335 1990 147 149
9. A. Lernmark, J.L. Molenaar, W.A. van Beers, Y. Yamaguchi, S. Nagataki, and J. Ludvigsson The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. The immunology and diabetes workshops and participating laboratories Diabetologia 34 1991 534 535
10. A.R. Mire-Sluis, R.G. Das, and A. Lernmark The development of a World Health Organisation international standard for islet cell antibodies: the aims and design of an international collaborative study Diabetes Metab Res Rev 15 1999 72 77
11. E.M. Tan, T.E. Feltkamp, J.S. Smolen, B. Butcher, R. Dawkins, and M.J. Fritzler Range of antinuclear antibodies in healthy individuals Arthritis Rheum 40 1997 1601 1611
12. A.J. Czaja, M. Nishioka, S.A. Morshed, and T. Hachiya Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis Gastroenterology 107 1994 200 207
13. G.F. Bottazzo, A. Florin-Christensen, A. Fairfax, G. Swana, D. Doniach, and U. Groeschel-Stewart Classification of smooth muscle autoantibodies detected by immunofluorescence J Clin Pathol 29 1976 403 410
14. B.H. Toh Smooth muscle autoantibodies and autoantigens Clin Exp Immunol 38 1979 621 628
15. E.L. Cancado, C.P. Abrantes-Lemos, L.S. Vilas-Boas, N.F. Novo, F.J. Carrilho, and A.A. Laudanna Thermolabile and calcium-dependent serum factor interferes with polymerized actin, and impairs anti-actin antibody detection J Autoimmun 17 2001 223 228
16. P. Muratori, L. Muratori, D. Agostinelli, G. Pappas, L. Veronesi, and A. Granito Smooth muscle antibodies and type 1 autoimmune hepatitis Autoimmunity 35 2002 497 500
17. A.J. Czaja, M.P. Manns, and H.A. Homburger Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis Gastroenterology 103 1992 1290 1295
18. M.J. Fritzler, and M.P. Manns Anti-mitochondrial autoantibodies Clin Appl Immunol Rev 3 2002 87 113
19. A.J. Czaja, H.A. Carpenter, and M.P. Manns Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis Gastroenterology 105 1993 1522 1528
20. P. Muratori, L. Muratori, M.E. Gershwin, A.J. Czaja, G. Pappas, and S. MacCariello True antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol 135 2004 154 158
21. F. Alvarez, O. Bernard, J.C. Homberg, and G. Kreibich Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum J Exp Med 161 1985 1231 1236
22. M. Gueguen, M. Meunier-Rotival, O. Bernard, and F. Alvarez Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily J Exp Med 168 1988 801 806
23. U.M. Zanger, H.P. Hauri, J. Loeper, J.C. Homberg, and U.A. Meyer Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II Proc Natl Acad Sci USA 85 1988 8256 8260
24. A.M. Yamamoto, C. Johanet, J.C. Duclos-Vallee, F.A. Bustarret, F. Alvarez, and J.C. Homberg A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay Clin Exp Immunol 108 1997 396 400
25. Y. Ma, G. Gregorio, J. Gaken, L. Muratori, F.B. Bianchi, and G. Mieli-Vergani Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection J Hepatol 26 1997 1396 1402
26. N. Kerkar, Y. Ma, E.T. Davies, P. Cheeseman, G. Mieli-Vergani, and D. Vergani Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays J Clin Pathol 55 2002 906 909
27. N. Abuaf, C. Johanet, P. Chretien, E. Martini, E. Soulier, and S. Laperche Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis Hepatology 16 1992 892 898
28. M. Lenzi, P. Manotti, L. Muratori, M. Cataleta, G. Ballardini, and F. Cassani Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection Gut 36 1995 749 754
29. S. Han, M. Tredger, G.V. Gregorio, G. Mieli-Vergani, and D. Vergani Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease Hepatology 21 1995 58 62
30. L. Muratori, M. Cataleta, P. Muratori, P. Manotti, M. Lenzi, and F. Cassani Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques J Immunol Methods 187 1995 259 264
31. P. Lapierre, O. Hajoui, J.C. Homberg, and F. Alvarez Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis Gastroenterology 116 1999 643 649
32. L. Muratori, E. Sztul, P. Muratori, Y. Gao, A. Ripalti, and C. Ponti Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1 Hepatology 34 2001 494 501
33. M. Bourdi, D. Larrey, J. Nataf, J. Bernuau, D. Pessayre, and M. Iwasaki Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis J Clin Invest 85 1990 1967 1973
34. M. Sacher, P. Blumel, H. Thaler, and M. Manns Chronic active hepatitis associated with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies J Hepatol 10 1990 364 369
35. M.G. Clemente, P. Obermayer-Straub, A. Meloni, C.P. Strassburg, V. Arangino, and R.H. Tukey Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1 J Clin Endocrinol Metab 82 1997 1353 1361
36. P. Obermayer-Straub, J. Perheentupa, S. Braun, A. Kayser, A. Barut, and S. Loges Hepatic autoantigens in patients with autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy Gastroenterology 121 2001 668 677
37. G.N. Dalekos, P. Obermayer-Straub, M. Bartels, T. Maeda, A. Kayser, and S. Braun Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection J Hepatol 39 2003 800 806
38. P. Beaune, P.M. Dansette, D. Mansuy, L. Kiffel, M. Finck, and C. Amar Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug Proc Natl Acad Sci USA 84 1987 551 555
39. O. Crivelli, C. Lavarini, E. Chiaberge, A. Amoroso, P. Farci, and F. Negro Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent Clin Exp Immunol 54 1983 232 238
40. T. Philipp, M. Durazzo, C. Trautwein, B. Alex, P. Straub, and J.G. Lamb Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D Lancet 344 1994 578 581
41. C.P. Strassburg, P. Obermayer-Straub, B. Alex, M. Durazzo, M. Rizzetto, and R.H. Tukey Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis Gastroenterology 111 1996 1576 1586
42. M.P. Manns, and P. Obermayer-Straub Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease Hepatology 26 1997 1054 1066
43. M. Manns, G. Gerken, A. Kyriatsoulis, M. Staritz, and K.H. Meyer zum Buschenfelde Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen Lancet 1 1987 292 294
44. E. Stechemesser, R. Klein, and P.A. Berg Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis Hepatology 18 1993 1 9
45. I. Wies, S. Brunner, J. Henninger, J. Herkel, S. Kanzler, and K.H. Meyer zum Buschenfelde Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis Lancet 355 2000 1510 1515
46. C. Gelpi, E.J. Sontheimer, and J.L. Rodriguez-Sanchez Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion Proc Natl Acad Sci USA 89 1992 9739 9743
47. M. Costa, J.L. Rodriguez-Sanchez, A.J. Czaja, and C. Gelpi Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis Clin Exp Immunol 121 2000 364 374
48. M. Volkmann, L. Martin, A. Baurle, H. Heid, C.P. Strassburg, and C. Trautwein Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis Hepatology 33 2001 591 596
49. M. Baeres, J. Herkel, A.J. Czaja, I. Wies, S. Kanzler, and E.L. Cancado Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics Gut 51 2002 259 264
50. Y. Ma, M. Okamoto, M.G. Thomas, D.P. Bogdanos, A.R. Lopes, and B. Portmann Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease Hepatology 35 2002 658 664
51. S. Vitozzi, I. Djilali-Saiah, P. Lapierre, and F. Alvarez Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis Autoimmunity 35 2002 485 492
52. A.J. Czaja, P.T. Donaldson, and A.W. Lohse Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis Am J Gastroenterol 97 2002 413 419
53. F.J. van der Woude, N. Rasmussen, S. Lobatto, A. Wiik, H. Permin, and L.A. van Es Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis Lancet 1 1985 425 429
54. R.J. Falk, and J.C. Jennette Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis N Engl J Med 318 1988 1651 1657
55. A.H. Mulder, G. Horst, E.B. Haagsma, P.C. Limburg, J.H. Kleibeuker, and C.G. Kallenberg Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases Hepatology 17 1993 411 417
56. S.R. Targan, C. Landers, A. Vidrich, and A.J. Czaja High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis Gastroenterology 108 1995 1159 1166
57. D.S. Bansi, K.A. Fleming, and R.W. Chapman Antineutrophil cytoplasmic antibodies in autoimmune hepatitis Gastroenterology 109 1995 2049 2050
58. D. Zauli, S. Ghetti, A. Grassi, C. Descovich, F. Cassani, and G. Ballardini Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis Hepatology 25 1997 1105 1107
59. B. Terjung, U. Spengler, T. Sauerbruch, and H.J. Worman Atypical p-ANCA in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines Gastroenterology 119 2000 310 322
60. B. Terjung, H.J. Worman, V. Herzog, T. Sauerbruch, and U. Spengler Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy Clin Exp Immunol 126 2001 37 46